Dr. Torbjørn Bjerke, MD, is a Portfolio Manager at Arctic Fund Management AS, an Independent Director at DBV Technologies SA, a Chairman at SynAct Pharma AB and a Portfolio Manager at Arctic Aurora LifeScience.
He is on the Board of Directors at DBV Technologies SA.
He has over more than 25 years of executive experience within successful drug development and business development/M&A in both public and private science companies.
Dr. Bjerke was previously employed as a Chairman by Pergamum AB, a Chief Executive Officer by Karolinska Development AB, a Chief Executive Officer by Karolinska Development AB (Private Equity), a Chairman, President & Chief Executive Officer by Orexo AB, an Independent Director by NeuroSearch A/S, a President & Chief Executive Officer by Biolipox AB, a Vice Chairman by Action Pharma A/S, an Executive Vice President-Research & Development by ALK-Abello A/S, a Director-Inflammation Pharmacology by AstraZeneca AB, a Chairman by NeoDynamics AB, a Member-Executive Board by TBIOTECH ApS, and a Founder by TXP Pharma GmbH.
He also served on the board at Action Pharma Holding I A/S, Aprea Therapeutics AB, Axela AB, Axelar AB, KDev Investments AB, Pharmanest AB, Selskabet af 20.02.2002 ApS and Topotarget A/S.
Mr. Bjerke got his doctor degree from the University of Aarhus.